FI973277A0 - Farmaseuttisia valmisteita TNF:n estämiseksi - Google Patents

Farmaseuttisia valmisteita TNF:n estämiseksi

Info

Publication number: FI973277A0
Authority: FI; Finland
Prior art keywords: tnf; inhibition; pharmaceutical preparations; preparations; pharmaceutical
Prior art date: 1995-02-10

Application number

FI973277A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI973277A (fi

Inventor

Hermann Graf

Helmut Wachtel

Herbert Schneider

Daryl Faulds

Daniel Perez

Harald Dinter

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-10

Filing date

1997-08-08

Publication date

1997-08-08

1997-08-08 Application filed by Schering Ag filed Critical Schering Ag

1997-08-08 Publication of FI973277A publication Critical patent/FI973277A/fi

1997-08-08 Publication of FI973277A0 publication Critical patent/FI973277A0/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Oncology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Psychiatry (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
AIDS & HIV (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)

FI973277A 1995-02-10 1997-08-08 Farmaseuttisia valmisteita TNF:n estämiseksi FI973277A0 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19505516		1995-02-10
PCT/DE1996/000257 WO1996024350A1 (de)	1995-02-10	1996-02-09	Pharmazeutische präparate zur tnf-inhibition

Publications (2)

Publication Number	Publication Date
FI973277A FI973277A (fi)	1997-08-08
FI973277A0 true FI973277A0 (fi)	1997-08-08

Family

ID=7754327

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI973277A FI973277A0 (fi)	1995-02-10	1997-08-08	Farmaseuttisia valmisteita TNF:n estämiseksi

Country Status (14)

Country	Link
US (1)	US6117895A (es)
EP (1)	EP0804192A1 (es)
JP (1)	JPH11500110A (es)
KR (1)	KR19980702116A (es)
CN (1)	CN1173818A (es)
AU (1)	AU706159B2 (es)
CZ (1)	CZ290671B6 (es)
FI (1)	FI973277A0 (es)
HU (1)	HUP9702408A3 (es)
IL (1)	IL117090A (es)
MX (1)	MX9706086A (es)
SK (1)	SK283821B6 (es)
WO (1)	WO1996024350A1 (es)
ZA (1)	ZA961081B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2300813A1 (en) *	1997-08-21	1999-03-04	Hiroyuki Odaka	Anti-inflammatory agent
US20040220103A1 (en) *	1999-04-19	2004-11-04	Immunex Corporation	Soluble tumor necrosis factor receptor treatment of medical disorders
DOP2005000123A (es) *	2004-07-02	2011-07-15	Merck Sharp & Dohme	Inhibidores de cetp
AR057218A1 (es) *	2005-12-15	2007-11-21	Astra Ab	Compuestos de oxazolidinona y su uso como pontenciadores del receptor metabotropico de glutamato

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2413935A1 (de) *	1974-03-20	1975-10-16	Schering Ag	4-(polyalkoxy-phenyl)-2-pyrrolidone
DE2541855A1 (de) *	1975-09-18	1977-03-31	Schering Ag	4-(polyalkoxy-phenyl)-2-pyrrolidone ii
FR2358155A1 (fr) *	1976-07-15	1978-02-10	Lapinet Eugene	Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
DE2655369A1 (de) *	1976-12-03	1978-06-08	Schering Ag	5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung
US5783591A (en) *	1984-10-19	1998-07-21	Schering Aktiengesellschaft	Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
DE3438839A1 (de) *	1984-10-19	1986-04-24	Schering AG, 1000 Berlin und 4709 Bergkamen	Pharmazeutische praeparate
US5310732A (en) *	1986-02-03	1994-05-10	The Scripps Research Institute	2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis
DE3639225A1 (de) *	1986-11-14	1988-05-19	Schering Ag	Verwendung von 5-(subst. phenyl)-oxazolidinonderiaten als psychopharmaka
WO1991000092A1 (en) *	1989-06-13	1991-01-10	Smithkline Beecham Corporation	Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
CA2088352A1 (en) *	1990-08-03	1992-02-04	Klaus M. Esser	Tnf inhibitors
PT100441A (pt) *	1991-05-02	1993-09-30	Smithkline Beecham Corp	Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
US5227369A (en) *	1991-07-11	1993-07-13	The Regents Of The University Of California	Compositions and methods for inhibiting leukocyte adhesion to cns myelin
GB9204808D0 (en) *	1992-03-04	1992-04-15	Rhone Poulenc Rorer Ltd	Novel compositions of matter
US5264437A (en) *	1992-03-20	1993-11-23	Syntex (U.S.A.) Inc.	Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
US5672622A (en) *	1994-04-21	1997-09-30	Berlex Laboratories, Inc.	Treatment of multiple sclerosis

1996
- 1996-02-09 SK SK1073-97A patent/SK283821B6/sk unknown
- 1996-02-09 ZA ZA961081A patent/ZA961081B/xx unknown
- 1996-02-09 AU AU47122/96A patent/AU706159B2/en not_active Ceased
- 1996-02-09 MX MX9706086A patent/MX9706086A/es not_active IP Right Cessation
- 1996-02-09 CZ CZ19972513A patent/CZ290671B6/cs not_active IP Right Cessation
- 1996-02-09 EP EP96902870A patent/EP0804192A1/de not_active Withdrawn
- 1996-02-09 JP JP8523903A patent/JPH11500110A/ja not_active Ceased
- 1996-02-09 WO PCT/DE1996/000257 patent/WO1996024350A1/de not_active Application Discontinuation
- 1996-02-09 IL IL11709096A patent/IL117090A/xx not_active IP Right Cessation
- 1996-02-09 HU HU9702408A patent/HUP9702408A3/hu unknown
- 1996-02-09 CN CN96191868A patent/CN1173818A/zh active Pending
- 1996-02-10 KR KR1019970705511A patent/KR19980702116A/ko not_active Application Discontinuation
- 1996-07-18 US US08/683,467 patent/US6117895A/en not_active Expired - Fee Related
1997
- 1997-08-08 FI FI973277A patent/FI973277A0/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUP9702408A2 (hu)	1998-05-28
JPH11500110A (ja)	1999-01-06
US6117895A (en)	2000-09-12
FI973277A (fi)	1997-08-08
KR19980702116A (ko)	1998-07-15
AU4712296A (en)	1996-08-27
AU706159B2 (en)	1999-06-10
ZA961081B (en)	1996-10-15
WO1996024350A1 (de)	1996-08-15
CN1173818A (zh)	1998-02-18
EP0804192A1 (de)	1997-11-05
HUP9702408A3 (en)	2000-08-28
SK283821B6 (sk)	2004-02-03
MX9706086A (es)	1997-10-31
SK107397A3 (en)	1997-12-10
CZ251397A3 (en)	1997-12-17
CZ290671B6 (cs)	2002-09-11
IL117090A0 (en)	1996-06-18
IL117090A (en)	2000-07-26

Publication	Publication Date	Title
DE69629755D1 (de)	2003-10-09	Irbesartanhaltiges Arzneimittel
NO962606D0 (no)	1996-06-19	Farmasöytisk sammensetning
BR9610153A (pt)	1999-01-05	Formulações farmacêuticas
BR9611626A (pt)	1999-06-01	Formulações farmacéuticas
NO954146D0 (no)	1995-10-18	Belagte farmasöytiske preparater
FI972945A (fi)	1997-07-11	Antigeenien antamiseen soveltuvia koostumuksia
PT858325E (pt)	2002-12-31	Formulacao farmaceutica liofilizada estavel
PT892640E (pt)	2004-06-30	Composicoes farmaceuticas de micofenolato entericamente revestidas
FI930882A (fi)	1993-08-29	Farmaceutiska foereningar
BR9610396A (pt)	1999-07-06	Formulação farmacêutica
KR970000228A (ko)	1997-01-21	S-에토돌락의 경구용 제제
BR9610214A (pt)	1999-06-15	Compostos farmacéuticos
FI931251A (fi)	1993-09-25	Farmaceutiska foereningar
FI973280A0 (fi)	1997-08-08	Farmaseuttinen koostumus
FI973230A (fi)	1997-08-05	Uusi farmaseuttinen formulaatio
FI973277A0 (fi)	1997-08-08	Farmaseuttisia valmisteita TNF:n estämiseksi
NO951933L (no)	1995-06-30	Farmasöytiske formuleringer av ibuprofen
DE59610423D1 (de)	2003-06-12	Partikulare arzneiform
NO965448L (no)	1997-06-20	Farmasöytiske forbindelser
BR9307182A (pt)	1999-03-30	Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
IT1277117B1 (it)	1997-11-04	Composizioni farmaceutiche per il trattamento delle ipercolesterolemie
BR9605777A (pt)	1998-08-25	Composição farmacêutica
LV11966A (lv)	1998-02-20	Pretiekaisumu lidzeklis arigai lietosanai
BR9605131A (pt)	1998-07-07	Composição farmacêutica
NO931014D0 (no)	1993-03-19	Farmasoeytisk preparat

Legal Events

Date	Code	Title	Description
2005-08-31	MA	Patent expired